https://www.moneycontrol.com/news/business/stocks/zydus-lifesciences-hits-52-week-high-on-usfda-approval-for-osteoporosis-drug-10435231.html
0
0
4/19/23 at 4:02am
Organization
Moneycontrol
Author
Moneycontrol News
Estradiol Transdermal System USP, 0.014 mg/day (weekly) had annual sales of $1.9 million in the United States.
Create an account
or login to join the discussion